SEC Form D filing
Anodyne Nanotech, Inc.
Biotech · Series B · Regulation D 506(b) · MA · Filed June 11, 2026
Offering amount
$17.3M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
June 11, 2026
Signature date
June 11, 2026
CIK
0001818572
Summary
Auto-generatedtransdermal drug delivery nanotechnology company, $17.3M series-b raise in MA
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.